These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 89854)

  • 1. Preliminary studies on nasal decongestant activity from the seed of the shea butter tree, Butyrospermum parkii.
    Tella A
    Br J Clin Pharmacol; 1979 May; 7(5):495-7. PubMed ID: 89854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal decongestants in monotherapy for the common cold.
    Deckx L; De Sutter AI; Guo L; Mir NA; van Driel ML
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD009612. PubMed ID: 27748955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa.
    Ferguson BJ; Paramaesvaran S; Rubinstein E
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrospermum parkii butter increased the photostability and in vivo SPF of a molded sunscreen system.
    Sarruf FD; Sauce R; Candido TM; Oliveira CA; Rosado C; Velasco MVR; Baby AR
    J Cosmet Dermatol; 2020 Dec; 19(12):3296-3301. PubMed ID: 32385930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nasal decongestant effect of xylometazoline in the common cold.
    Eccles R; Eriksson M; Garreffa S; Chen SC
    Am J Rhinol; 2008; 22(5):491-6. PubMed ID: 18655753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
    Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA
    Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
    Eccles R; Martensson K; Chen SC
    Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The observation of the ciliotoxicity of nasal mucosa with nasal decongestant].
    Teng Y; Zhang X; Xu G; Cai Q; Xu J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Sep; 19(18):824-6. PubMed ID: 16375111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Shea (Butyrospermum parkii) butter, TiO
    Sarruf FD; Cândido TM; de Oliveira CA; Bou-Chacra NA; Robles Velasco MV; Baby AR
    J Cosmet Dermatol; 2020 Aug; 19(8):2076-2085. PubMed ID: 31856404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
    Druce HM; Ramsey DL; Karnati S; Carr AN
    Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental study comparing burn healing effects of raw South African Shea butter and the samples from a Libyan market.
    Treesh SA; Saadawi SS; Alennabi KA; Aburawi SM; Lotfi K; Ben Musa AS
    Open Vet J; 2021 Jan; 10(4):431-437. PubMed ID: 33614438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 45-Year-Old Man With Delayed Onset of OSA Events During Polysomnography.
    Barone DA; Krieger AC
    Chest; 2016 Apr; 149(4):e123-6. PubMed ID: 27055717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of Cytotoxic Effects of Oxymetazoline on Lungs in a Rat Model of Rhinitis Medicamentosa.
    Cengiz B; Bostancıklıoğlu M; Demir T; Karabulut H; Dokuyucu R; Ulaşlı M
    Curr Mol Pharmacol; 2021 Oct; 14(4):658-666. PubMed ID: 32718303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of micronized cellulose powder on the efficacy of topical oxymetazoline in allergic rhinitis.
    Valerieva A; Popov TA; Staevska M; Kralimarkova T; Petkova E; Valerieva E; Mustakov T; Lazarova T; Dimitrov V; Church MK
    Allergy Asthma Proc; 2015; 36(6):e134-9. PubMed ID: 26133030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery - A systematic review.
    Macmillan AJ; Phoon KM; Edafe O
    Int J Pediatr Otorhinolaryngol; 2022 Feb; 153():111010. PubMed ID: 34942425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W; Grubbe R; Weiss S; Lutsky B
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apical ballooning syndrome secondary to nasal decongestant abuse.
    Wang R; Souza NF; Fortes JA; Santos GJ; Faria Neto JR; Zytinski L
    Arq Bras Cardiol; 2009 Nov; 93(5):e75-8. PubMed ID: 20084298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.